The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
Application of a multi-stacked fentanyl patch could result in serious, life-threatening, or fatal respiratory depression.
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid addiction in the United States.
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...